NOVOLIN Safety Questions, NOVOLIN Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about NOVOLIN. Our extensive database of NOVOLIN adverse events and NOVOLIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about NOVOLIN

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



NOVOLIN Safety Reports

Total NOVOLIN reports: 146.
NOVOLIN FDA safety alerts: No.
Reported deaths: 2    Reported hospitalizations: 89.
Take NOVOLIN Side Effects Survey or Share Your NOVOLIN Story. Read More Here.

Showing 1-75 of 146 Next >

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Feb 10, 2006. Male patient, 78 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. NOVOLIN dosage: unknown. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on June 14, 2006. Male patient, 72 years of age, weighting 220.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma. NOVOLIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Aug 26, 2005. Female patient, 72 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, decreased appetite, diarrhoea. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOPEN. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2005. Male patient, 58 years of age, weighting 220.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma, hypoglycaemic seizure. NOVOLIN dosage: unknown. During the same period patient was treated with COZAAR, LIPITOR, ACTOS, PRILOSEC, FIBERCON, FOLIC ACID, ASPIRIN, LEXAPRO. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Nov 16, 2005. Male patient was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 29, 2005. Female patient, 77 years of age, weighting 190.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOPEN, AMARYL, LOPRESSOR, PREVACID, RESTORIL, ISOSORBIDE, LEVOTHYROXINE, LISINOPRIL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NOVOLIN problem on Dec 27, 2005. Female patient was diagnosed with blood glucose increased and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. NOVOLIN dosage: unknown. Patient recovered.

NOVOLIN problem was reported by a Pharmacist from UNITED STATES on Jan 18, 2006. Female patient was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic seizure. NOVOLIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported NOVOLIN problem on Apr 13, 2006. Male patient, 45 years of age, was diagnosed with diabetes mellitus non-insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. NOVOLIN dosage: unknown. During the same period patient was treated with SUSTIVA, ABACAVIR SULPHATE, PROZAC, ZANTAC, LISINOPRIL, PREDNISONE. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Pharmacist from UNITED STATES on Apr 19, 2006. Female patient was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction. NOVOLIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported NOVOLIN problem on May 05, 2006. Female patient was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hypersensitivity. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLOG. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from UNITED STATES on Aug 09, 2006. Female patient, 45 years of age, weighting 224.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, blood ketone body, renal haemorrhage. NOVOLIN dosage: unknown. During the same period patient was treated with AVANDIA. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NOVOLIN problem on Oct 18, 2006. Male patient, 63 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus, ill-defined disorder, hypertension, musculoskeletal pain, depression and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, pyrexia. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, ASPIRIN, FELODIPINE, LISINOPRIL, METOPROLOL TARTRATE, NAPROSYN, BUPROPION. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 54 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, diabetes mellitus inadequate control. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, HUMALOG, LANTUS, HUMALOG NPL. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported NOVOLIN problem on Aug 09, 2006. Female patient, weighting 225.8 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, kidney infection, renal haemorrhage, urine ketone body. NOVOLIN dosage: unknown. During the same period patient was treated with AVANDIA. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Nov 06, 2006. Male patient, 58 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, suicide attempt. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN R. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Nov 14, 2006. Female patient, 76 years of age, was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: incorrect dose administered. NOVOLIN dosage: unknown. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Nov 08, 2006. Female patient, 34 years of age, weighting 108.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: gastric cancer. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on Nov 08, 2006. Female patient, 29 years of age, weighting 103.6 lb, was diagnosed with diabetes mellitus malnutrition-related and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: gastric cancer. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 54 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, diabetes mellitus inadequate control. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN N, NOVORAPID CHU FLEXPEN, NOVORAPID CHU FLEXPEN, HUMALOG, LANTUS, HUMALOG NPL. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on Nov 06, 2006. Female patient, 52 years of age, weighting 103.6 lb, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody. NOVOLIN dosage: unknown. During the same period patient was treated with INNOLET. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on July 26, 2006. Male patient, 60 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, inflammation, liver disorder. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on Nov 06, 2006. Female patient, 52 years of age, weighting 103.6 lb, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody. NOVOLIN dosage: unknown. During the same period patient was treated with INNOLET, HUMALOG. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Nov 08, 2006. Female patient, 34 years of age, weighting 108.0 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: gastric cancer. NOVOLIN dosage: unknown. During the same period patient was treated with PENFILL N CHU, LASIX, BLOPRESS, ADALAT, FLUITRAN, ONEALFA. Patient recovered.

Consumer or non-health professional from JAPAN reported NOVOLIN problem on Oct 30, 2006. Male patient, 54 years of age, weighting 138.9 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, diabetes mellitus inadequate control. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, NOVOLIN N, NOVORAPID CHU FLEXPEN, NOVORAPID CHU FLEXPEN, HUMALOG, LANTUS. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Pharmacist from UNITED STATES on Oct 16, 2006. Male patient, 63 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus, ill-defined disorder, hypertension, musculoskeletal pain, depression, coronary artery disease and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, pyrexia. NOVOLIN dosage: unknown. During the same period patient was treated with ASPIRIN, FELODIPINE, LISINOPRIL, METOPROLOL SUCCINATE, NAPROSYN, BUPROPION, CRESTOR, VARDENAFIL. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NOVOLIN problem on Oct 18, 2006. Male patient, 63 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus, ill-defined disorder, hypertension, musculoskeletal pain, depression and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, pyrexia, viral infection. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, ASPIRIN, FELODIPINE, LISINOPRIL, METOPROLOL SUCCINATE, NAPROSYN, BUPROPION. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Dec 08, 2006. Female patient, 35 years of age, weighting 132.3 lb, was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: abortion threatened, autonomic neuropathy, blood glucose fluctuation, caesarean section, creatinine renal clearance decreased, diabetic autonomic neuropathy, gastrointestinal hypomotility, hypertension. NOVOLIN dosage: unknown. During the same period patient was treated with HUMALOG, HYDRALAZINE. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on Dec 16, 2005. Male patient, 70 years of age, weighting 97.00 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, insomnia, anaemia, hepatic function abnormal and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, autoimmune disorder, diabetes mellitus inadequate control, diabetic ketoacidosis, injection site erythema, injection site pruritus, skin test positive. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN R, NOVORAPID CHU, HALCION, FERROMIA, TATHION, NORVASC. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Dec 08, 2006. Female patient, 35 years of age, weighting 132.3 lb, was diagnosed with diabetes mellitus insulin-dependent and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation, caesarean section, diabetic autonomic neuropathy, hypertensive nephropathy, hypoglycaemic unconsciousness, pregnancy, pulmonary oedema, vomiting. NOVOLIN dosage: unknown. During the same period patient was treated with HUMALOG, HYDRALAZINE. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NOVOLIN problem on June 26, 2007. Female patient, 82 years of age, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, hypoglycaemia. NOVOLIN dosage: unknown. Patient was hospitalized. Patient died on 06/10/2007.

NOVOLIN problem was reported by a Physician from JAPAN on July 03, 2007. Male patient, 54 years of age, was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, suicide attempt. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, ANTIDEPRESSANTS. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on July 09, 2007. Female patient, 63 years of age, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood glucose fluctuation, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, hepatic function abnormal, hepatocellular damage. NOVOLIN dosage: unknown. During the same period patient was treated with NATEGLINIDE, BASEN, MIGLITOL. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from JAPAN on July 11, 2007. Male patient, 70 years of age, weighting 97.00 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, insomnia, anaemia, hepatic function abnormal and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: anti-insulin antibody positive, diabetic ketoacidosis, injection site erythema, injection site pruritus, skin test positive. NOVOLIN dosage: unknown. During the same period patient was treated with HUMACART R, NOVOLIN N, NOVOLIN R, NOVORAPID CHU, HALCION, FERROMIA, URSO. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on July 27, 2007. Male patient, 57 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: localised infection. NOVOLIN dosage: unknown. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on July 31, 2007. Female patient, 65 years of age, weighting 97.00 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, gastric ulcer and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. NOVOLIN dosage: unknown. During the same period patient was treated with STOGAR, GLUCOBAY, EPATAT, PROHEPARUM. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on Aug 09, 2007. Male patient, 59 years of age, was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, suicide attempt. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, ANTIDEPRESSANTS. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from UNITED STATES on Aug 07, 2007. Male patient, 48 years of age, weighting 424.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, eye pain, headache, vision blurred. NOVOLIN dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.

Pharmacist from UNITED STATES reported NOVOLIN problem on Aug 15, 2007. Female patient, weighting 130.0 lb, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, mental status changes. NOVOLIN dosage: unknown. During the same period patient was treated with ATACAND HCT, CARDIZEM, FISH OIL. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Aug 08, 2007. Female patient, 65 years of age, weighting 97.00 lb, was diagnosed with insulin-requiring type ii diabetes mellitus, gastric ulcer and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hepatic function abnormal. NOVOLIN dosage: unknown. During the same period patient was treated with STOGAR, GLUCOBAY, EPATAT, PROHEPARUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Aug 14, 2007. Male patient, 61 years of age, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: diabetic ketoacidosis, impaired gastric emptying, myocardial infarction. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Female patient was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, fall. NOVOLIN dosage: unknown. During the same period patient was treated with LANTUS. Patient recovered.

Health Professional from UNITED STATES reported NOVOLIN problem on Aug 21, 2006. Female patient, 58 years of age, weighting 119.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose fluctuation. NOVOLIN dosage: unknown. During the same period patient was treated with IMITREX. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 07, 2007. Female patient, 77 years of age, weighting 102.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Oct 06, 2006. Female patient, 81 years of age, weighting 119.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, loss of consciousness. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOPEN. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 08, 2007. Female patient, 80 years of age, weighting 145.1 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOFINE, NOVOLOG, MACROBID, LASIX, LIPITOR, COREG, SENNA. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on June 01, 2007. Male patient, 55 years of age, weighting 190.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. NOVOLIN dosage: unknown. During the same period patient was treated with GLIMEPIRIDE, DIOVAN, COREG, METFORMIN, LISINOPRIL, STATIN, ACTOS. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 02, 2007. Female patient, 80 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, SIMVASTATIN, GEMFIBROZIL, TOPROL, ENTERIC ASPIRIN, LEVOXYL, CLARITIN, CENTRUM. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Apr 02, 2007. Female patient, 80 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. During the same period patient was treated with FUROSEMIDE, SIMVASTATIN, GEMFIBROZIL, TOPROL, ENTERIC PAIN, CLARITIN, LEVOXYL, CENTRUM. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 23, 2007. Male patient, 58 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. During the same period patient was treated with LANTUS, LISINOPRIL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on June 01, 2007. Male patient, 75 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. NOVOLIN dosage: unknown. During the same period patient was treated with ALENDRONATE, HYDROCHLOROTHIAZIDE, SYNTHROID, LISINOPRIL, SIMVASTATIN, METFORMIN, ASPIRIN, CALCIUM. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Pharmacist from UNITED STATES on Nov 27, 2006. Female patient, 70 years of age, weighting 144.0 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: rash pruritic. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N. Patient recovered.

Health Professional from UNITED STATES reported NOVOLIN problem on Jan 02, 2007. Male patient, 58 years of age, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN N, LISINOPRIL, SYNTHROID, ZOCOR. Patient recovered.

NOVOLIN problem was reported by a Pharmacist from UNITED STATES on Jan 04, 2007. Female patient was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, incorrect dose administered. NOVOLIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Feb 23, 2007. Male patient, 72 years of age, weighting 203.0 lb, was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN R. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 28, 2007. Female patient, 59 years of age, weighting 110.0 lb, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLIN R, FOSAMAX, CALCIUM, PREMARIN. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on May 07, 2007. Male patient, 25 years of age, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic coma. NOVOLIN dosage: unknown. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on July 05, 2007. Female patient, 61 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: burning sensation, lip swelling, pharyngeal oedema, pruritus. NOVOLIN dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Aug 13, 2007. Male patient, 54 years of age, weighting 160.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: fall, head injury, hypoglycaemic unconsciousness. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLOG, BENICAR, ATENOLOL, ALTACE, TOPROL. Patient recovered.

NOVOLIN problem was reported by a Pharmacist from UNITED STATES on Sept 11, 2006. Female patient, 34 years of age, was diagnosed with gestational diabetes and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, diabetic ketoacidosis. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Apr 23, 2007. Female patient, 49 years of age, weighting 190.9 lb, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, influenza like illness. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from UNITED STATES on Apr 09, 2007. Male patient, 91 years of age, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, hypersensitivity. NOVOLIN dosage: unknown. Patient recovered.

Health Professional from UNITED STATES reported NOVOLIN problem on May 30, 2007. Male patient, 19 years of age, was diagnosed with diabetic ketoacidosis and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, headache, overdose. NOVOLIN dosage: 6 ML/HR., INTRAVENOUS. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Health Professional from UNITED STATES on June 13, 2007. Female patient was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, overdose. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

Pharmacist from UNITED STATES reported NOVOLIN problem on June 26, 2007. Female patient, 89 years of age, was diagnosed with diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

NOVOLIN problem was reported by a Physician from UNITED STATES on May 02, 2007. Female patient was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, eye pain, headache, vision blurred. NOVOLIN dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.

Consumer or non-health professional from UNITED STATES reported NOVOLIN problem on Aug 29, 2007. Female patient was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: asthenia, back pain, blood glucose increased, dysarthria, muscle spasms, myalgia, presyncope. NOVOLIN dosage: unknown. During the same period patient was treated with NOVOLOG. Patient recovered.

NOVOLIN problem was reported by a Physician from JAPAN on Sept 05, 2007. Female patient, 38 years of age, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic encephalopathy. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

Physician from UNITED STATES reported NOVOLIN problem on May 02, 2007. Female patient was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: blood glucose increased, eye pain, headache, vision blurred. NOVOLIN dosage: unknown. During the same period patient was treated with HUMALOG. Patient recovered.

NOVOLIN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 10, 2007. Female patient was diagnosed with insulin-requiring type ii diabetes mellitus, hypertension and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemia, hypotension. NOVOLIN dosage: unknown. During the same period patient was treated with ANTIHYPERTENSIVES. Patient was hospitalized. Patient recovered.

Physician from JAPAN reported NOVOLIN problem on Sept 14, 2007. Female patient, 38 years of age, was diagnosed with type 1 diabetes mellitus and was treated with NOVOLIN. After drug was administered, patient experienced the following problems/side effects: hypoglycaemic encephalopathy. NOVOLIN dosage: unknown. Patient was hospitalized. Patient recovered.

Showing 1-75 of 146 Next >

Ask Our Patient Community about NOVOLIN

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal